21 results Discover our SPC booklet Our Brussels IP/Life Sciences team has authored a booklet on the case-law of the Court of justice of the EU (CJEU) regarding supplementary protection certificates (SPCs). Proposal to amend European Emission Trading Scheme (ETS) in context of Fit-for-55 One component of the Fit-for-55 climate package is a revision of the European Emissions Trading System (ETS) to allow the ETS to also contribute to the target of 55% reduction in greenhouse gases by 2030 compared to 1990. Actualiteiten Internationaal Maatschappelijk Verantwoord Ondernemen (IMVO) De aandacht voor (I)MVO en ESG en verantwoording daarover blijft onverminderd groot. Wij zien op nationaal en Europees niveau tal van ontwikkelingen. Wij stippen enkele Europese en nationale initiatieven aan. Nynke Brouwer new senior associate at Stibbe We are pleased to announce that Nynke Brouwer will be joining Stibbe’s Amsterdam office as senior associate. Her appointment as from 13 June 2022 will further strengthen our TMT/IP practice. Proposal for a Directive on Corporate Sustainability Due Diligence On 23 February 2022 the European Commission (the "Commission") published a proposal for a Directive on Corporate Sustainability Due Diligence (the "CSDD proposal"). Barbra Bulsing Senior Associate Amsterdam Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare. Louis Bidaine Associate Brussels Philippe Campolini Partner Brussels Vince Van der Wangen Associate Brussels Ignace Vernimme Partner Brussels Nathan Thys Junior Associate Brussels Mari Muzashvili Junior Associate Brussels Anya Murphy Junior Associate Brussels Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Kate Criel Junior Professional Support Lawyer Brussels Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Pagination Current page 1 Page 2 Next page
Discover our SPC booklet Our Brussels IP/Life Sciences team has authored a booklet on the case-law of the Court of justice of the EU (CJEU) regarding supplementary protection certificates (SPCs).
Proposal to amend European Emission Trading Scheme (ETS) in context of Fit-for-55 One component of the Fit-for-55 climate package is a revision of the European Emissions Trading System (ETS) to allow the ETS to also contribute to the target of 55% reduction in greenhouse gases by 2030 compared to 1990.
Actualiteiten Internationaal Maatschappelijk Verantwoord Ondernemen (IMVO) De aandacht voor (I)MVO en ESG en verantwoording daarover blijft onverminderd groot. Wij zien op nationaal en Europees niveau tal van ontwikkelingen. Wij stippen enkele Europese en nationale initiatieven aan.
Nynke Brouwer new senior associate at Stibbe We are pleased to announce that Nynke Brouwer will be joining Stibbe’s Amsterdam office as senior associate. Her appointment as from 13 June 2022 will further strengthen our TMT/IP practice.
Proposal for a Directive on Corporate Sustainability Due Diligence On 23 February 2022 the European Commission (the "Commission") published a proposal for a Directive on Corporate Sustainability Due Diligence (the "CSDD proposal").
Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.